These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1803451)

  • 41. [Newly discovered role of glomerulonephritis mediators].
    Baud L
    Presse Med; 1998 Jan; 27(2):69-71. PubMed ID: 9768058
    [No Abstract]   [Full Text] [Related]  

  • 42. Viral infections, their influence on some parts of the immune system and glomerulonephritis development.
    Steciwko A
    Int Urol Nephrol; 1987; 19(4):433-9. PubMed ID: 3323103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood.
    Mastrangelo A; Serafinelli J; Giani M; Montini G
    Front Pediatr; 2020; 8():205. PubMed ID: 32478016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analytical pathology. II. Histopathologic demonstration of glomerular-localizing antibodies in experimental glomerulonephritis.
    MELLORS RC; ARIAS-STELLA J; SIEGEL M; PRESSMAN D
    Am J Pathol; 1955; 31(4):687-715. PubMed ID: 14388127
    [No Abstract]   [Full Text] [Related]  

  • 45. Ten-year advances in immunopathology of glomerulonephritis: translated into patients' care or lost in translation?
    Ronco P; Floege J
    Semin Immunopathol; 2014 Jul; 36(4):377-9. PubMed ID: 25056156
    [No Abstract]   [Full Text] [Related]  

  • 46. Immune reactions in human glomerulonephritis.
    FISCHEL EE
    J Chronic Dis; 1957 Jan; 5(1):34-44. PubMed ID: 13376701
    [No Abstract]   [Full Text] [Related]  

  • 47. [New method for the induction of experimental glomerulonephritis].
    BEREGI E
    Virchows Arch Pathol Anat Physiol Klin Med; 1957; 330(4):391-401. PubMed ID: 13530660
    [No Abstract]   [Full Text] [Related]  

  • 48. [Distinct phases of glomerulonephritis].
    HERNANDEZ ESQUIVEL C; ROJAS E
    Rev Invest Clin; 1951 Apr; 3(2):203-20. PubMed ID: 24541555
    [No Abstract]   [Full Text] [Related]  

  • 49. Nephritogenic immune reactions involving immune complex formation in the circulation and in situ within the kidney.
    Wilson CB; Neale TJ; Holdsworth SR
    Aust N Z J Med; 1981; 11(Suppl 1):88-93. PubMed ID: 6455118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antigenic targets in epimembranous glomerulonephritis. Experimental data and potential application in human pathology.
    Ronco P; Allegri L; Brianti E; Chatelet F; Van Leer EH; Verroust P
    Appl Pathol; 1989; 7(2):85-98. PubMed ID: 2567175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Contribution of experimental pathology to the understanding of human immune glomerulonephritis].
    Ronco P; Verroust P; Chatelet F
    Rev Prat; 1991 Nov; 41(24):2411-8. PubMed ID: 1803451
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokines in glomerulonephritis.
    Tipping PG; Holdsworth SR
    Semin Nephrol; 2007 May; 27(3):275-85. PubMed ID: 17533006
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.